Literature DB >> 19758186

Toll-like receptors in multiple sclerosis mouse experimental models.

Monica Marta1.   

Abstract

Certain pathogen molecules trigger innate immune responses and drive subsequent adaptive immune responses toward an antigen presented simultaneously. Such bacterial or viral molecules constitute pathogen-associated molecular patterns (PAMPs) that bind to pattern-recognition receptors such as toll-like receptors (TLRs). Recently, endogenous molecules were identified that ligate the same receptors. The role of these receptors' response to complete Freund's adjuvant during initiation of CD4 T cell responses in EAE, the animal model for multiple sclerosis, is here discussed. Myeloid differentiation primary response gene 88 (MyD88) is necessary for the induction of experimental autoimmune encephalomyelitis (EAE), and it is required for the activation of myeloid dendritic cells and differentiation of T helper 17 cells. The role of individual TLR, in particular TLR3, TLR4, and TLR9, signaling in modulation of EAE inflammation varies with the experimental model employed and the immune cells that drive pathology. The TLR-dependent production of proinflammatory cytokines is regulated by mechanisms that dampen the pathway and prevent excess damage. Development of TLR antagonists to treat autoimmune diseases must acknowledge the possibility of interference with regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758186     DOI: 10.1111/j.1749-6632.2009.04849.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

Review 1.  Immune modulating peptides for the treatment and suppression of multiple sclerosis.

Authors:  Ahmed H Badawi; Teruna J Siahaan
Journal:  Clin Immunol       Date:  2012-06-05       Impact factor: 3.969

Review 2.  The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Authors:  Jeffery J Auletta; Amelia M Bartholomew; Richard T Maziarz; Robert J Deans; Robert H Miller; Hillard M Lazarus; Jeffrey A Cohen
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

3.  Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls.

Authors:  Andrea T White; Alan R Light; Ronald W Hughen; Timothy A Vanhaitsma; Kathleen C Light
Journal:  Psychosom Med       Date:  2011-12-30       Impact factor: 4.312

4.  Filarial lymphatic pathology reflects augmented toll-like receptor-mediated, mitogen-activated protein kinase-mediated proinflammatory cytokine production.

Authors:  Subash Babu; R Anuradha; N Pavan Kumar; P Jovvian George; V Kumaraswami; Thomas B Nutman
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

5.  Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats.

Authors:  Lisa C Loram; Paige W Sholar; Frederick R Taylor; Julie L Wiesler; Jessica A Babb; Keith A Strand; Debra Berkelhammer; Heidi E W Day; Steven F Maier; Linda R Watkins
Journal:  Psychoneuroendocrinology       Date:  2012-04-10       Impact factor: 4.905

6.  Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.

Authors:  Omri Zveik; Ariel Rechtman; Nitzan Haham; Irit Adini; Tamar Canello; Iris Lavon; Livnat Brill; Adi Vaknin-Dembinsky
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

7.  Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.

Authors:  Srividya Sriskantharajah; Eva Gückel; Niki Tsakiri; Katrin Kierdorf; Christine Brender; Abduelhakem Ben-Addi; Marc Veldhoen; Philip N Tsichlis; Brigitta Stockinger; Anne O'Garra; Marco Prinz; George Kollias; Steven C Ley
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

8.  Inhibition of lipopolysaccharide-induced microglia activation by calcitonin gene related peptide and adrenomedullin.

Authors:  Alessandra Consonni; Stefano Morara; Franca Codazzi; Fabio Grohovaz; Daniele Zacchetti
Journal:  Mol Cell Neurosci       Date:  2011-07-22       Impact factor: 4.314

Review 9.  Is there a causal link between inflammation and dementia?

Authors:  Ana-Maria Enciu; Bogdan O Popescu
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

10.  Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis.

Authors:  John-Mark Fitzpatrick; Becky Hackett; Lisa Costelloe; William Hind; Eric J Downer
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.